|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2004;77:1503-1504
© 2004 The Society of Thoracic Surgeons
Division of Surgery, Toneyama National Hospital, 5-1-1, Toneyama, Toyonaka, Osaka 560-8552, Japan
e-mail: nsawabata{at}m5.dion.ne.jp
To the Editor:
Lee and colleagues [1] discussed the impact of implanting iodine-125 seeds along the resection margin in patients who had undergone limited resection for lung cancer. They concluded that this combined treatment achieved acceptable survival and local control in the majority of compromised patients with stage IA disease.
We believe that radiotherapy can control local recurrence at the surgical margin. However, surgical margin relapses occur only at malignant cellpositive surgical margins [2, 3]. Because there was no information on the ratio of positive to negative surgical margins in the study of Lee and associates, it is difficult to gauge the potential to reduce the number of recurrences at the margins. This point arises because in a small series of patients, 2 patients had surgical margin relapses even though they underwent brachytherapy.
It is very easy to evaluate the malignant status of the surgical margin. Only two slides are required when using our run-across method. Tissue is collected from the margin with one slide and then spread over the other [4]. We recommend that the run-across method be used in a prospective, randomized multicenter clinical trial to accurately validate the results of radiotherapy and to find out how many patients truly benefit from this treatment.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |